Aurinia Pharmaceuticals(DE:IKAP)
€14.40-0.22 (-1.54%)
DE:IKAP
Aurinia Pharmaceuticals earnings date
€14.40
At close:-0.22 (-1.54%)
Aurinia Pharmaceuticals (IKAP) Q2 2021 Earnings Report
1 Followers
DE:IKAP Q2 2021 EPS Results
- Actual EPS
- -EUR 0.33
- Consensus EPS
- -EUR 0.32
- Beat/Miss
- Missed by -EUR 0.00
- One Year Ago EPS
- -EUR 0.26
DE:IKAP Q2 2021 Revenue Results
- Actual Revenue
- EUR 5.89M
- Expected Revenue
- EUR 4.41M
- Beat/Miss
- Beat by +EUR 1.48M
- YoY Revenue Growth
- +22727.59%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/05/2021
- Time
- After Close
- Conference Call
- Thursday, August 5, 2021
DE:IKAP Upcoming Earnings
Aurinia Pharmaceuticals's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:IKAP Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | 0.19- | 1.36 | ― | ― |
| Oct 30, 2026 | 2026 (Q3) | 0.200.20 | 0.2 | 0.00% (+0.00) | |
| Aug 06, 2026 | 2026 (Q2) | 0.210.25 | 0.14 | 75.00% (+0.11) | |
| May 07, 2026 | 2026 (Q1) | 0.170.22 | 0.14 | 56.25% (+0.08) | |
| Feb 26, 2026 | 2025 (Q4) | 0.191.36 | 0.01 | 15200.00% (+1.35) | |
| Nov 04, 2025 | 2025 (Q3) | 0.140.20 | 0.09 | 130.00% (+0.12) | |
| Jul 31, 2025 | 2025 (Q2) | 0.130.14 | 0.01 | 1500.00% (+0.13) | |
| May 12, 2025 | 2025 (Q1) | 0.090.14 | -0.06 | 328.57% (+0.20) | |
| Feb 27, 2025 | 2024 (Q4) | -0.010.01 | -0.17 | 105.26% (+0.18) | |
| Nov 07, 2024 | 2024 (Q3) | 0.010.09 | -0.08 | 211.11% (+0.17) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
